Clinical Trial Update: Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on an ongoing Phase 1/2 clinical trial evaluating pomalidomide, dexamethasone, and pegylated liposomal doxorubicin for relapsed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Pegylated liposomal doxorubicin (pegylated liposomal doxorubicin)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Oncotherapeutics | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: UNKNOWN